We showed, in a model of in vitro NK cell differentiation, that IL-1β-releasing AML blasts could inhibit the recovery of CD34+-derived CD161+CD56+ cells, resulting in a reduced generation of ILC3 and NK cells [84]. This evidence concerns the gene IL1B and acute myeloid leukemia.